Please wait a minute...
Clinical and Experimental Obstetrics & Gynecology  2015, Vol. 42 Issue (4): 510-514    DOI: 10.12891/ceog1911.2015
Original Research Previous articles | Next articles
The expression of Forkhead transcription factors in decidua and placenta in patients with missed abortion
K. Ozbilgin1, *(), B. Kahraman1, A. Turan2, C. Atay3, S. Vatansever1, S. İnan1, T. Özçakır4
1Department of Histology and Embryology, School of Medicine Celal Bayar University, Manisa
2Departments of Gynecology and Obstetrics, Ercis State Hospital, Van
3Department of Computer Technologies, Izmir University of Economics, Balcova, Izmir
4Department of Gynecology and Obstetrics, School of Medicine Celal Bayar University, Manisa (Turkey)
Download:  PDF(452KB)  ( 10 )
Export:  BibTeX | EndNote (RIS)      
Abstract  
Background: Forkhead transcription factors 3a (FOXO3a) has pleiotropic biological functions in the female reproductive tract. FOXO3a has a function in decidualization, in placental development, and also in inhibition of apoptosis. This study aims to investigate a possible role of FOXO3a in missed abortion. Materials and Methods: Decidual and placental tissue samples were obtained from the women with unwanted pregnancy as the control group and with missed abortion as the patient group. Immunohistochemistry technique was utilized to compare FOXO3a expression of the decidual cells in uterine decidual stroma and cytotrophoblast-syncytiotrophoblast cells in placental villous stroma. Immunohistochemistry was evaluated semi-quantitatively utilizing the H-score technique. Results: It was demonstrated that H-Scores of FOXO3a expression in both uterine decidual stroma were increased in the missed abortion group (255.83±12.41) than in the normal pregnancy group (133.33±17.43). It was also shown that there was no difference between non-decidual area of the endometrium of the normal pregnancy and the missed abortion group (30.33±4.32; 39.66±14.30, respectively) and placental villous stroma (13.00±1.89; 13.00±1.67, respectively). However, the immunoreactivity of cytotrophoblast and syncytiotrophoblast cells significantly increased in the missed abortion group (18.83±1.47; 322.00±6.06, respectively) than in the normal pregnancy group (11.00±1.26; 254.00±8.17, respectively) (p < 0.05). Conclusion: These data support the hypothesis that increased FOXO3a expression in missed abortion may prevent the discharge of dead fetus to maintain decidualization, prevention of oxidative stress, immunomodulation, and inhibition of apoptosis.
Key words:  Forkhead transcription factors 3a      Decidua      Placenta      Missed abortion     
Published:  10 August 2015     
*Corresponding Author(s):  K. OZBILGIN     E-mail:  kemalozbilgin@yahoo.com

Cite this article: 

K. Ozbilgin, B. Kahraman, A. Turan, C. Atay, S. Vatansever, S. İnan, T. Özçakır. The expression of Forkhead transcription factors in decidua and placenta in patients with missed abortion. Clinical and Experimental Obstetrics & Gynecology, 2015, 42(4): 510-514.

URL: 

https://ceog.imrpress.com/EN/10.12891/ceog1911.2015     OR     https://ceog.imrpress.com/EN/Y2015/V42/I4/510

[1] Ryuichi Shimaoka, Tomomi Shiga, Ken-ichirou Morishige. Effect of ritodrine tocolysis on fetal cardiac output distribution to the placenta[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(5): 1126-1131.
[2] Mahmoud Alalfy, Soha Talaat Hamed, Alaa Sobhi Abd El Ghani, Ahmed Elgazzar, Amr Abbassy, Ahmed S. S. A. Rashwan, Omar Nagy, Mohamed A Shalaby, Hatem Hassan, Asmaa Ibrahem, Hesham Kamal, Reham Mahrous, Eman Kamal. The accuracy of 3D-TUI and 3D power Doppler using Alalfy simple criteria in the diagnosis of placenta accreta spectrum[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(5): 1132-1140.
[3] Silvia Amodeo, Giulia Bonavina, Anna Seidenari, Paolo Ivo Cavoretto, Antonio Farina. Real-world implementation and adaptation to local settings of first trimester preeclampsia screening in Italy: a systematic review[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(4): 812-819.
[4] Mengdie Luo, Junxing Li, Xiaofeng Yang, Qiang Huang, Mengwei Huang, Jie Mei. Intraoperative infrarenal aortic balloon occlusion in pregnancies with placenta accreta spectrum disorder[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(3): 487-493.
[5] Eren Akbaba. Can high transverse skin incision (Modified Maylard) be a new alternative in placenta accreta spectrum management with cesarean hysterectomy?[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(3): 686-690.
[6] Yu Huang, Fang-Yuan Luo. Clinical efficacy of aortic balloon occlusion during caesarean section in patients with placenta accreta spectrum disorders: a systematic review and meta-analysis[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(2): 234-244.
[7] Kumari Anukriti, Kiran Guleria, Vipin Tyagi, Amita Suneja, B D Banerjee. Maternal blood and amnionic oxytocin receptor gene expression and serum oxytocin levels in preterm birth: a case-control study[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(2): 283-291.
[8] Ryuichi Shimaoka, Tomomi Shiga, Ken-ichirou Morishige. Change in uterine artery blood flow with intrauterine balloon tamponade[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(2): 307-311.
[9] Saša Raičević, Duško Kljakić, Filip Vukmirović, Miloš Z. Milosavljević. A giant placental chorioangioma with a resultant live birth; a discussion of management options[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(2): 426-430.
[10] Suchaya Luewan, Pakorn Chaksuwat, Tip Pongsuvareeyakul, Theera Tongsong. Prenatal sonographic findings and management of placental mesenchymal dysplasia[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(2): 439-443.
[11] Wassan Nori, Muna Abdulghani, Ali B Roomi, Wisam Akram. To operate or to wait? Doppler indices as predictors for medical termination for first trimester missed abortion[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(1): 168-174.
[12] E. Destegül, S. Gençdal, İ. Sarı, H. Akkaya, B. Çakmak, N. Gençdal. Maternal serum levels of SCUBE1 in missed abortion[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(6): 862-866.
[13] H.M. Kim, Y.J. Chin, H.H. Cha, W.J. Seong, M.J. Kim. Placenta accreta and uterine rupture of unscarred uterus in patients with systemic lupus erythematosus with prolonged steroid exposure: a report of two cases[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(5): 785-788.
[14] G. Garuti, E. Castellacci, S. Calabrese, S. Calzolari. Hysteroscopic removal of retained products of conception with enhanced vascularity: a study of reliability[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 472-477.
[15] J. Wang, S.W. Chen, X.Y. Qin, X.Z. Zheng, P. Wang, X.Y. Cai. Clinical application of short tandem repeat polymorphism analysis in the differential diagnosis of early hydatidiform mole and hydropic abortion[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 490-495.
No Suggested Reading articles found!